Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis.
about
IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFNγClinical biomarkers and pathogenic-related cytokines in rheumatoid arthritisThe critical role of IL-34 in osteoclastogenesisCytokine-modulating strategies and newer cytokine targets for arthritis therapy.Divergent antiviral roles of amphibian (Xenopus laevis) macrophages elicited by colony-stimulating factor-1 and interleukin-34.Integrative genomic analyses of a novel cytokine, interleukin-34 and its potential role in cancer prediction.An RNA-seq protocol to identify mRNA expression changes in mouse diaphyseal bone: applications in mice with bone property altering Lrp5 mutationsTargeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategyThe newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation.Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicityPositive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritisModern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor.Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice.Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis.Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patientsIL-34 is a Treg-specific cytokine and mediates transplant tolerance.Proteoglycans and osteolysisCancer to bone: a fatal attraction.Osteoclasts-Key Players in Skeletal Health and Disease.Amphibian macrophage development and antiviral defenses.Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management.Functions of interleukin-34 and its emerging association with rheumatoid arthritis.BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma.A review on interleukins: The key manipulators in rheumatoid arthritis.Immunoregulatory properties of the cytokine IL-34.Interleukin-34 induces monocytic-like differentiation in leukemia cell lines.IL-1β and TNFα promote monocyte viability through the induction of GM-CSF expression by rheumatoid arthritis synovial fibroblasts.Key Triggers of Osteoclast-Related Diseases and Available Strategies for Targeted Therapies: A Review.Differentiation-dependent antiviral capacities of amphibian (Xenopus laevis) macrophages.1α,25-Dihydroxyvitamin D3 up-regulates IL-34 expression in SH-SY5Y neural cells.High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers.IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential.Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue.AG490 suppresses interleukin-34-mediated osteoclastogenesis in mice bone marrow macrophages.Pro-osteoclastic in vitro effect of Polyethylene-like nanoparticles: Involvement in the pathogenesis of implant aseptic loosening.Novel RANK antagonists for the treatment of bone-resorptive disease: theoretical predictions and experimental validation.Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma.Interleukin-34 sustains inflammatory pathways in the gut.Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.Mechanisms of Fish Macrophage Antimicrobial Immunity.
P2860
Q24317213-B285133D-8D4A-4EAA-801D-A17FC69961C3Q27022559-AA9FF26C-070B-4402-9147-D95452644C61Q33873578-C2525621-1699-4432-B9C7-37B24CF92258Q34456715-D955EF1B-3034-401B-A195-EA4BEFD74C7AQ34484106-5EF577F6-7D5C-4C23-9C12-D7B30A7CA795Q34599064-B931782C-E0A3-488F-AD29-C1270ABC6185Q34647373-A3AB1C73-A5E5-42A6-8481-E055CDAD22BCQ34902134-A7F490D9-45DD-4956-A77B-9D42BF34D7EFQ35067581-20A7FDFD-B6B1-496B-A07B-02F074E4956CQ35235779-62E089CB-95C7-4A0D-B135-A26F0D6100FCQ35617594-26FC6BAF-7062-4FA1-9FFC-EBD5EDC53E61Q35988028-93A3185A-6080-4837-AC90-2946DA868E48Q36056520-C5AC4779-38EC-4C19-9507-15094C562254Q36084929-D511D6BF-ADCB-47E9-BF61-B7D0050ED51DQ36146539-2AF3E845-88A7-4A7A-A07D-99F1A187367BQ36165650-E594C792-1C3D-4719-AA65-106A76B065B8Q36203010-1058ACB3-C5C4-4450-80F0-5EC00F661F19Q36884628-E5A92759-6692-40D1-861D-17E71E5EE8BAQ37036135-1FC2E8AA-D28A-49F5-98E3-C26EE85AE14FQ38679771-F7F0B7B2-68B4-4B36-9715-2E940AB6C991Q38805260-91C3321B-D8AE-446B-ACF7-6A159A20B951Q38934355-4063F9AB-C926-4367-AD64-3C06756A048AQ38981617-E566085C-88F0-46BB-8459-E6B975FB0874Q39029629-27853B1D-6B54-4BC8-BBC7-CAA36ED52B44Q39160565-602A1A54-8287-41C0-8951-F23A1F5ED068Q41052789-4CF57591-E641-431E-B599-846349982570Q43050400-0864A280-D0EB-415C-A10D-CC6EE4DC4AF9Q47400369-1AABA80B-6109-43C3-846D-B1BBAD3FFDF0Q47563332-008177AC-6233-4CE6-9751-9181CCEC6F51Q48150940-6A283E4B-D18D-4BC4-AAC8-EE27537BE5BAQ48263052-DA2670B4-D8FA-45AC-A704-769B43847AE7Q49303424-963E1DF8-2C61-4EFB-9D4E-C38A7C3872FEQ50105682-EBAF5F0F-D0D3-4BBC-8901-643B2456DCCDQ50748716-34617855-6884-461C-B0A2-114B2D9617D6Q51307098-16AC87C5-403F-4DD9-9B99-35603E6F93F8Q51760981-8CC682A3-CD32-43D0-8B07-23325F5A8FB4Q52668254-97CA053F-3C78-47E0-AF29-21005B5D1E7DQ54282841-1002EF4F-CF15-4891-8DE3-20398D53729FQ54369171-2BB1026D-5CBE-44E1-83C9-D458ED7753F5Q55014189-56DA49D9-5A38-47A5-AD5E-54E4163B4A5F
P2860
Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Interleukin-34 is expressed by ...... KL-induced osteoclastogenesis.
@en
Interleukin-34 is expressed by ...... KL-induced osteoclastogenesis.
@nl
type
label
Interleukin-34 is expressed by ...... KL-induced osteoclastogenesis.
@en
Interleukin-34 is expressed by ...... KL-induced osteoclastogenesis.
@nl
prefLabel
Interleukin-34 is expressed by ...... KL-induced osteoclastogenesis.
@en
Interleukin-34 is expressed by ...... KL-induced osteoclastogenesis.
@nl
P2093
P356
P1476
Interleukin-34 is expressed by ...... KL-induced osteoclastogenesis.
@en
P2093
Anne Moreau
Céline Charrier
François Gouin
Laurence Duplomb
Marc Baud'huin
Romain Renault
Régis Brion
P356
10.1002/PATH.2684
P577
2010-05-01T00:00:00Z